[ Price : $8.95]
Federal Register Final rule: FDA corrects an inaccurate citation in a regulatory hearing process regulation on biological products...[ Price : $8.95]
Former attorney general Dick Thornburgh says Kentuckys suit seeking damages for illegal use of OxyContin should be rejected.[ Price : $8.95]
FDA approves Amgens Nplate for stimulating blood platelet production in patients with chronic immune thrombocytopenic purpura.[ Price : $8.95]
FDA clarifies what it means by newly acquired information that is used to support labeling changes made to medical products in adv...[ Price : $8.95]
Attorney Arnold Friede says FDAs ruling in denying Watsons Camptosar citizen petition on generic labeling carve-outs may lead to a...[ Price : $8.95]
FDA grants OncoGenex a fast track designation for OGX-011 (custirsen sodium), indicated for combination use with docetaxel in trea...[ Price : $8.95]
FDA says it is looking into clinical trial reports of a possible association between Vytorin and an increased cancer risk.[ Price : $8.95]
We post to our Web site nine of the latest FDA-483s and related correspondence we have received from FDA pursuant to our Freedom o...